These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24392031)

  • 21. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
    Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
    Ishizaki E; Takai S; Ueki M; Maeno T; Maruichi M; Sugiyama T; Oku H; Ikeda T; Miyazaki M
    Am J Ophthalmol; 2006 Jan; 141(1):129-134. PubMed ID: 16386986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
    You JJ; Yang CM; Chen MS; Yang CH
    Retina; 2012 Jan; 32(1):103-11. PubMed ID: 21822163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
    J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-1 studies in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kosano H; Okano T; Katsura Y; Noritake M; Kado S; Matsuoka T; Nishigori H
    Life Sci; 1999; 64(25):2307-15. PubMed ID: 10374894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
    Noda K; Ishida S; Inoue M; Obata K; Oguchi Y; Okada Y; Ikeda E
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2163-70. PubMed ID: 12714657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
    Lu Q; Lu L; Chen W; Lu P
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM; Kangave D; Opdenakker G
    Acta Diabetol; 2013 Jun; 50(3):363-71. PubMed ID: 22864860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
    Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
    Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
    Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
    Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
    Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
    Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Kangave D; Abouammoh M; Mohammad G
    Mediators Inflamm; 2012; 2012():697489. PubMed ID: 23118492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.
    Izuta H; Chikaraishi Y; Adachi T; Shimazawa M; Sugiyama T; Ikeda T; Hara H
    Mol Vis; 2009 Dec; 15():2663-72. PubMed ID: 20011081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
    Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
    Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
    Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.